AP

AuGC partners

North America, California, United States, Belmont

Description

AuGC Partners handles equity investments in fundamentally undervalued public biotechnology

Investor Profile

AuGC partners has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Post Ipo Equity rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Medical Device, Therapeutics.

Stage Focus

  • Post Ipo Equity (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Medical Device
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does AuGC partners frequently co-invest with?

AC
North America, Maryland, United States, Baltimore
Co-Investments: 1
Nantahala Capital Management
North America, Connecticut, United States, New Canaan
Co-Investments: 1
Second Line
North America, Louisiana, United States, New Orleans
Co-Investments: 1
Co-Investments: 1

What are some of recent deals done by AuGC partners?

Cellectar Biosciences

Madison, Wisconsin, United States

Cellectar Biosciences is a pharmaceutical research company specializing in cancer drugs.

BiotechnologyMedical DeviceTherapeutics
Post Ipo EquitySep 5, 2023
Amount Raised: $103,000,000